New research demonstrates that a candidate COVID-19 vaccine elicited robust immune response in Syrian golden hamsters and prevented severe clinical disease — including weight loss, pneumonia and death.
Investigational COVID-19 vaccine candidate prevents severe clinical disease in animals
